Understanding Generalized Pustular Psoriasis to Improve Patient Outcomes
Guest Editor
Anzeige
Peter C. M. van de Kerkhof
Department of Dermatology, Radboud University Medical Centre,
Nijmegen, The Netherlands
Peter.vandeKerkhof@radboudumc.nl
Anzeige
Disclosures: This supplement was wholly funded by Boehringer Ingelheim. Medical writing support provided by OPEN Health Communications (London, UK) was also funded by Boehringer Ingelheim.
Guest Editor Conflicts of Interest:
Peter C.M. van de Kerkhof: Acted as an investigator and/or consultant for Almirall, AbbVie, Boehringer Ingelheim, Dermavant, Eli Lilly, Novartis, Janssen, LEO Pharma, Bristol Myers Squibb, and UCB.
Reviewer Conflicts of Interest:
Anonymous: Acted as an investigator and/or consultant for AbbVie, Anaptys Bio, Boehringer Ingelheim, Bristol Myers Squibb, InflaRx, Incyte, Janssen, Novartis, Pfizer, UCB, and Viela Biosciences.
Anonymous: Acted as an investigator and/or consultant for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Galderma, Stiefel, Janssen‐Cilag, LEO Pharma, Merck Serono International, MSD, Novartis, and Pfizer.
Masashi Akiyama: No conflicts of interest.
Jose M. Carrascosa: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Almirall, Amgen, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Sandoz, and UCB.
Anzeige
Jeffrey J. Crowley: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Boehringer Ingelheim, Dermira, Eli Lilly, Janssen-Cilag, MC2 Therapeutics, Merck, Novartis, Pfizer, Regeneron, Sandoz, Sanofi, Sun Pharma, UCB, and Verrica Pharmaceuticals.
Giovanni Damiani: No conflicts of interest.
Hideki Fujita: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Chugai Pharmaceutical, Esai, Eli Lilly, Janssen, Japan Blood Products Organization, JMEC, Kaken, Kyorin, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi-Tanabe, Nihon Pharmaceutical, Novartis, Sanofi, Sun Pharma, Taiho Pharmaceutical, Torii, UCB, and Ushio.
George Han: Acted as an investigator and/or consultant and/or invited speaker for Abbvie, Amgen, Athenex, Boehringer Ingelheim, Bond Avillion, Bristol Myers Squibb, Castle Biosciences, Celgene, Dermavant, Dermtech, Eli Lilly, Janssen, LEO Pharma, MC2, MedX, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharma, and UCB.
Anzeige
Hideaki Myachi: Acted as an invited speaker for AbbVie, GK Pharmaceuticals, Janssen, KK Pharmaceuticals, and Taiho Pharmaceutical.
Ulrich Mrowietz: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Aditxt, Almirall, Amgen, Aristea, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Dr. Reddy’s, Eli Lilly, Foamix, Formycon, Immunic, Janssen, LEO Pharma, Medac, MetrioPharm AG, Novartis, Phi-Stone AG, Pierre Fabre, Sanofi-Aventis, and UCB.
Tarun Narang: No conflicts of interest.
Yukari Okubo: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Celgene, Eisai, Eli Lilly Japan, Janssen, KK Pharmaceuticals, Kyowa Kirin, Maruho, Novartis, Shiseido, Taiho Pharmaceutical, and Torii.
Anzeige
Wiebke Peitsch: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Actelion, ALK-Abello, Alma Lasers, Almirall Hermal, ARC Lasers, Array Biopharma, Asclepion, Beiersdorf, Biotest, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Dermapharm, Dermasence, Dr. Pfleger, Eli Lilly, Galderma, GlaxoSmithKline, Immunocore, Janssen-Cilag, La Roche Posay, LEO Pharma, L'Oreal, Medac, MSD, Mylan, Novartis, Pierre Fabre, Pfizer, P&M Cosmetics, Roche, Sanofi, Sun Pharma, and UCB.
Adam Reich: Acted as an investigator and/or consultant and/or invited speaker for AbbVie, Bioderma, Celgene, Chema-Elektromet, Drug Delivery Solutions Ltd, Eli Lilly, Galderma, Genentech, Janssen, Kymab Ltd, LEO Pharma, Medac, Menlo Therapeutics, MetrioPharm AG, MSD, Novartis, Pfizer, Pierre Fabre, Sandoz, and Trevi Therapeutics.
Thierry Simonart: No conflicts of interest.
Tiago Torres: Acted as an investigator and/or consultant for AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, LEO Pharma, MSD, Novartis, Pfizer, Samsung Bioepis, Sandoz, Sanofi, and UCB.
Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.